Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Diabetes.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03554200
What this trial is testing

EMPA Acute Heart Failure

Who this might be right for
Diabetes Mellitus, Type 2Acute Heart Failure
RWTH Aachen University 19
Early research (Phase 1)Study completedNCT01784211
What this trial is testing

LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 76
Testing effectiveness (Phase 2)Study completedNCT04077671
What this trial is testing

CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer

Who this might be right for
Diabetic Neuropathic Foot Ulcers
Chiesi Farmaceutici S.p.A. 93
Not applicableStudy completedNCT04782999
What this trial is testing

Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesObesity, Morbid
Hvidovre University Hospital 9
Large-scale testing (Phase 3)Study completedNCT02889510
What this trial is testing

Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Lecube, Albert, M.D. 76
Not applicableEnded earlyNCT03184662
What this trial is testing

Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesDiabetic Kidney Disease
Poitiers University Hospital 178
Post-approval studies (Phase 4)UnknownNCT04584242
What this trial is testing

Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Who this might be right for
Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
Yonsei University 40
Not applicableStudy completedNCT04320069
What this trial is testing

Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study

Who this might be right for
Type 1 Diabetes
Insulet Corporation 25
Large-scale testing (Phase 3)Study completedNCT06415773
What this trial is testing

Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Shenzhen HighTide Biopharmaceutical Ltd. 367
Not applicableStudy completedNCT07423559
What this trial is testing

Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients

Who this might be right for
Diabetic KetoacidosisInsulinIntensive Care Unit Stay
Tanta University 100
Not applicableUnknownNCT05061459
What this trial is testing

The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Assiut University 96
Not applicableStudy completedNCT05351359
What this trial is testing

MHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes

Who this might be right for
Type 2 DiabetesPreDiabetes
Charles University, Czech Republic 343
Not applicableStudy completedNCT05936203
What this trial is testing

Management of Prolonged Aerobic exeRcise in Patients With Type 1 Diabetes on Advanced Technologies

Who this might be right for
Type1diabetes
Federico II University 18
Testing effectiveness (Phase 2)Study completedNCT01237119
What this trial is testing

Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
University of Birmingham 52
Not applicableNot Yet RecruitingNCT07263802
What this trial is testing

Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism

Who this might be right for
Impaired Fasting Glucose (IFG)Impaired Glucose Tolerance (Prediabetes)
Fondazione IRCCS Policlinico San Matteo di Pavia 90
Not applicableStudy completedNCT01313975
What this trial is testing

Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury

Who this might be right for
Electrolyte DisturbancesSubarachnoid HemorrhageTraumatic Brain Injury+1 more
Insel Gruppe AG, University Hospital Bern 85
Not applicableStudy completedNCT01566981
What this trial is testing

E-health Care Process Support for Diabetes Type II Patients

Who this might be right for
Diabetes Mellitus Type II,
University of Primorska 120
Testing effectiveness (Phase 2)Study completedNCT02370537
What this trial is testing

Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI

Who this might be right for
Diabetes Mellitus, Type 2Exocrine Pancreatic Insufficiency
AstraZeneca 490
Early research (Phase 1)Study completedNCT02703337
What this trial is testing

LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 30
Not applicableNot Yet RecruitingNCT07515677
What this trial is testing

Digital Discharge Planning to Improve Self-Management in Patients With Diabetes Mellitus

Who this might be right for
Diabetes (DM)
Universitas Muhammadiyah Surakarta 78
Next Page